Article ID Journal Published Year Pages File Type
8458619 Radiotherapy and Oncology 2018 9 Pages PDF
Abstract
We tested the predictive value of a “31-gene signature” and PD-L1 expression status in a dataset of patients with lower grade glioma. Our results suggest that the patient population classified as the PD-L1-high-RR may benefit most from radiotherapy combined with anti-PD-1/PD-L1 treatment. Prospective clinical trial is necessary to validate the findings in a homogenous treated patient cohort.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, ,